Patients to whom we prescribe second-generation (“atypical”) antipsychotics are increased risk of metabolic syndrome. On another page on this website, we have discussed guidelines for monitoring patients who are on a second-generation antipsychotic. Unfortunately, many studies show that the rates of this monitoring being actually done are quite low. One of the many reasons for…